Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials

Published:2009-05 Issue:5 Volume:31 Page:962-979
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Machado Márcio,Cruz Lorena Souza,Tannus Gabriela,Fonseca Marcelo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference85 articles.

1. Metastatic Bone Disease: Fundamental and Clinical Aspects;Diel,1994

2. The management of metastatic bone disease in the United Kingdom. The Breast Specialty Group of the British Association of Surgical Oncology;Eur J Surg Oncol.,1999

3. Skeletal complications of malignancy;Coleman;Cancer,1997

4. Cancer statistics, 2001 [published correction appears in CA Cancer J Clin. 2001;51:144];Greenlee;CA Cancer J Clin.,2001

5. Metastatic bone disease: Clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev.,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaktische Strahlentherapie bei asymptomatischen Hochrisiko-Knochenmetastasen;Strahlentherapie und Onkologie;2024-01-05

2. Bisphosphonates, Denosumab, and Anabolic Agents in the Treatment of Metastatic Bone Disease;Metastatic Bone Disease;2024

3. Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review;Journal of Oncology Pharmacy Practice;2023-10-09

4. Atteintes non rhumatismales de la paroi thoracique antérieure;L'actualité Rhumatologique 2023-2024;2023

5. Etidronate-based organic salts and ionic liquids: In vitro effects on bone metabolism;International Journal of Pharmaceutics;2021-12